Biotechnology

Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions

Using patient personality traits to pioneer a new era in clinical research. MONT-SAINT-GUIBERT, Belgium, April 18, 2024 /PRNewswire/ -- Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, proudly announces a...

2024-04-18 21:00 250

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine

GAITHERSBURG, Md., April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-18 20:00 384

Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"

MELBOURNE, Australia, April 18, 2024 /PRNewswire/ -- Australia's newest biotech incubatorJumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awaitedMelbourne-based facility at an ...

2024-04-18 11:00 885

Q1 2024 Revenue and Business Update

MELBOURNE, Australia, April 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended31 March 2024 (Q1 2024). Summary: Q1 2024 financial performance  The Company reports unaudi...

2024-04-17 15:05 1007

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN ASIA

— Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant — – World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee – — Indian Organizations Chennai Liver Foundation and FIND Receive the Grant t...

2024-04-17 11:22 1085

SCG CELL THERAPY AND A*STAR LAUNCH JOINT LABS WITH COLLABORATION NEARING S$30 MILLION TO ADVANCE iPSC TECHNOLOGY TOWARDS SCALABLE GMP MANUFACTURING OF CELLULAR IMMUNOTHERAPIES

* Collaboration aims to develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates to facilitate research leading to translation of novel cellular immunotherapies. * Launch of the joint labs builds on existing license, research collaboration and Memorandum of Understan...

2024-04-17 10:00 1123

CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution

MONROE, Ohio, April 16, 2024 /PRNewswire/ -- CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technolog...

2024-04-16 20:47 1182

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

GAITHERSBURG, Md., April 16, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-16 20:00 1272

Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions

* Kinetics is a globally leading provider of installation services and equipment  * Company serves high-tech industries such as semiconductor, biopharma, and batteries  * 2,500 employees at more than 20 locations worldwide  * Exyte to enter technical facility management business  * Exyte...

2024-04-16 17:00 934

Next Bio Invests in Hiperbaric High-Pressure Processing Technology to Ramp Up Cold Brew Coffee Production

* Leading South Korean Cold Brew Producer Installs Hiperbaric Industrial HPP System to Boost Capacity to 6,000 Tons Per Year. * HPP ensures the safety and shelf life of cold-brew coffee up to 90 days while maintaining its freshness and flavor. MIAMI, April 16, 2024 /PRNewswire/ -- Next Bio,...

2024-04-16 01:29 1099

TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is presenting for t...

2024-04-15 15:30 851

The 2024 Asia Agri-Tech Expo & Forum Demonstrates Taiwan's Prowess on Smart Farming & Biotechnology, brings in Future and Revolution to Agriculture, Livestock and Aquaculture Industries

TAIPEI, April 15, 2024 /PRNewswire/ -- Taiwan is renowned for its engineering prowess, manufacturing most of the components used in smart farming, including IoT sensors, solar panels, drones, robotics, and agriculture technology system integrators bringing revolutionary advancements to the field....

2024-04-15 09:00 1622

Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA

TOKYO, April 15, 2024 /PRNewswire/ -- Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted byJapan's Pharmaceuticals and Medical Devices Agency (PMDA).  As the official regulatory agency for pharmaceuticals inJapan, the PMDA holds significant resp...

2024-04-15 08:30 938

CSafe unveils cutting-edge innovations to meet cold chain customer needs

The company will launch three new technologies at the upcoming LogiPharma 2024 event MONROE, Ohio, April 10, 2024 /PRNewswire/ -- CSafe, a leading active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, announces it is launching three new technol...

2024-04-10 22:50 1734

MGI Tech Presents Latest Storage Product Series at ISBER 2024

MELBOURNE, Australia, April 10, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, today showcased its latest storage solutions catering to a variety of sample storage needs, including MGICLab-LT*, MGICLab-LN55K*, and M...

2024-04-10 17:18 1525

ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research

TOKYO, April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been launching a continuous stream of innovative organoid-related products. Displaying their advancements at key global forums including the 2024 International Organoid Summit, Alzheimer's Research UK Conference 2024, and ...

2024-04-10 14:05 1458

R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm

SHENZHEN, China, April 10, 2024 /PRNewswire/ -- Recently, Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd., had completed the enrollment of first p...

2024-04-10 11:41 1739

Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR

* The dose-escalation results of JSKN003 was reported at this AACR conference. * JSKN003 exhibited a favorable tolerability, safety profile and encouraging preliminary antitumor activity in patients with HER2-expressing advanced/metastatic solid tumors. The ORR in patients with HER2+ BC was 100...

2024-04-10 08:40 1522

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

GAITHERSBURG, Md., April 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-04-09 20:00 1156

Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA

* Sales double in the USA, order intake increases by over 150 percent * More than 50 percent increase in order intake in EMEA * Business Area Technology & Services' sales grow by almost 25 percent  * Further improvement in profitability * Exyte CEO Büchele: "Our follow-the-client strategy ...

2024-04-09 17:52 1404
12345 ... 166